Czarnetzki, B.M., König, W., Lichtenstein, L.M.
Eosinophil chemotactic factor (ECF) release from human polymorphonuclear neutrophils by calcium ionophore A 23187 and by phagocytosis.
Nature 258:725-726, 1975

Czarnetzki, B.M., König, W., Lichtenstein, L.M.
Antigen-induced eosinophil chemotactic factor (ECF) release by human leukocytes.
Inflammation 1:201-215, 1975

König, W., Czarnetzki, B.M., Lichtenstein, L.M.
Release of eosinophil chemotactic factor from human granulocytes by the calcium ionophore A 23187 and by phagocytosis.
Allergy Disease Center Conference (NIH) 1976

Czarnetzki, B.M., König, W., Lichtenstein, L.M.
Eosinophil chemotactic factor (ECF). I. Release from polymorphnuclear leukocytes by the calcium ionophore A 23187.
J. Immunol. 117:229-234, 1976

König, W., Czarnetzki, B.M., Lichtenstein, L.M.
Eosinophil chemotactic factor (ECF). II. Release during phagocytosis of human polymorphonuclear leukocytes.
J. Immunol. 117:235-245, 1976

König, W., Czarnetzki, B.M., Lichtenstein, L.M.
Generation and release of eosinophil chemotactic factor from polymorphnuclear leukocytes.
In: "Monographs in Allergy" - Mediators of the Immediate Type Inflammatory Reaction, 12:198-212, 1977
Karger-Verlag, Basel

König, W., Czarnetzki, B.M., Lichtenstein, L.M.
Eosinophil chemotactic factor (ECF). III. Generation in human peripheral leukocytes.
Int. Arch. All. Appl. Immunol. 56:364-375, 1978

König, W., Tesch, H., Frickhofen, N.
Generation and release of eosinophil chemotactic factor from human polymorphonuclear neutrophils by arachidonic acid.
Eur. J. Immunol. 8:434-437, 1978

Czarnetzki, B.M., König, W.
Modulation of eosinophil chemotaxis and eosinophilchemotactic factor (ECF)
Int. Arch. All. Appl. Immunol. 56:551-557, 1978

Czarnetzki, B.M., König, W., Lichtenstein, L.M.
Eosinophil chemotactic factor (ECF). IV. Inhibitors in human peripheral leukocytes.
Int. Arch. All. Appl. Immunol. 56:398-408, 1978

König, W., Czarnetzki, B.M.
Inactivation of eosinophil chemotactic factor (ECF) by normal human serum.
Int. Arch. All. Appl. Immunol. 57:399-410, 1978

König, W.
Struktur und Funktion des eosinophilen Leukozyten.
Immunität und Infektion 6:97-105, 1978

König, W., Frickhofen, N., Tesch, H.
Generation and secretion of eosinophilotactic activity from polymorphonuclear neutrophils by various mechanisms of cell activation.
Immunology 36:733-742, 1978

Frickhofen, N., König, W.
Subcellular localization of the eosinophil chemotactic factor (ECF) and its inactivator in human PMNs.
Immunology 37:111-122, 1979

Tesch, H., König, W., Frickhofen, N.
Eosinophil chemotactic factor: Release from human polymorphonuclear neutrophils by arachidonic acid.
Int. Arch. All. Appl. Immunol. 58:430-446 ,1979

König, W., Frickhofen, N., Tesch, H.
Generation of an eosinophilotactic factor from human PMNs by various mechanisms of cell activation.
In: "Function and Structure of the Immune System".
Plenum Press, Adv. Exp. Med. Biol. 114:521-528, 1979

Tesch, H., König, W.
Entstehung und Bedeutung der Lipidmediatoren für den Entzündungsablauf.
Immunität und Infektion, 157-164, 1979

König, W.
Importance of histamine in the allergic diagnostics and its determination on the Technicon autoanalyzer.
International Technicon Symposium, Paris 1979

Tesch, H., König, W.
Phospholipase A2 und arachidonic acid: a common link in the generation of the eosinophil chemotactic factor (ECF) from human PMNs by various stimuli.
Scand. J. Immunol. 11:409-418, 1980

Kroegel, C., König, W., Mollay, Ch., Kreil, G.
Generation of the eosinophil-chemotactic factor (ECF) from various cell types by melittin.
Molecular Immunology 18:227-236, 1981

Kroegel, C., Kunau, H.W., König, W.
Inhibition of the eosinophil chemotactic factor (ECF) release from human polymorphonuclear neutrophils (PMNs) and rat mast cells by arachidonic acid analogues.
Cell. Immunol. 60:480-488, 1981

König, W., Pfeiffer, Ph., Pison, U.
Immunoglobulin E (IgE) vermittelte Reaktionen.
Deutsche Medizinische Wochenschrift 106:1266-1271, 1981

König, W., Kroegel, C., Kunau, H.W., Borgeat, P.
Comparison of the eosinophil-chemotactic factor (ECF) with endogenous hydroxy-eicosaenoic acids of leukocytes.
In: "Monographs in Allergy", 66 (Suppl. I) 168-171, 1981

König, W., Pfeiffer, Ph., Kunau, H.W.
Effect of arachidonic acid metabolites in the histamine release from human basophils and rat mast cells.
In: "Monographs in Allergy", 66 (Suppl. I), 149-151, 1981

König, W., Bremm, K.D., Borgeat, P.
On the biological role of lipid chemotactic factors. Agents and Actions
Suppl.: First International Conference on Leukocyte, Locomotion and Chemotaxis. 12:167-185,1982 - Birkhäuser Verlag

König, W.
Receptor-mediated functions of the eosinophil granulocyte.
In: "Frontiers in cell surface receptor" - Suppl. to the Journal of Medicine,109-155, 1982.
PJD Publications LTD, Westbury, Research New York

König, W., Kunau, H.W., Borgeat, P.
Comparison of the eosinophil chemotactic factor with endogenous hydroxyeicosatetraenoic acids.
In. "Leukotrienes and other Lipoxygenase Products", Advances in Prostaglandin, Thromboxane and Leukotriene Research.
Raven Press 9:301-314,1982. (B. Samuelsson and R. Paoletti, eds)

König, W., Bohn, A., Bremm, K.D., Müller, P., Szperalski, B.Pfeiffer, Ph.
Leukotrienes and lipoxygenase factors. Mediators and modulators of the allergic reaction.
Allergologia et Immunopathologia 10:385-394, 1982

Aehringhaus, U., Wölbling, R.H., König, W., Patrono, C.,Peskar, B.M., Peskar, B.A.
Release of leukotriene C4 from human polymorphonuclear leukocytes as determined by radioimmunoassay.
FEBS-letters 146:111-114, 1982

König, W., Theobald, K., Pfeiffer, Ph., Szperalski, B.,Bremm, K.D., Bohn, A.
Biochemie der Mastzelle.
Der Anaesthesist 31:416, 1982

Spur, B., Crea, A., Peters, W., König, W.
Synthesis of 11,12,14,15 Tetrahydro-Leukotrien C,D,E via A.
Tetrahydron Letters, 2135, 1983

Spur, B., Crea, A., Peters, W., König, W.
Synthesis von 9,10,11,12,14,15-Hexahydro-leukotriene E.
Archiv der Pharmazie 316:572-574, 1983

König, W., Müller, P., Spur, B., Busse, H.D.
Interdependence of inflammatory signals in various immunological systems assayed with synthetic lipid mediators (leukotrienes and platelet activating factors).
Monographs in Allergy 18:201-205, 1983

Pison, U., Theobald, K., Bohn, A., Kunau, H.W., König, W.
Evidence for phospholipase-arachidonic acid involvement in anaphylatoxin-induced smooth muscle contraction and histamine release from mast cells.
Monographs in Allergy 18:206-210, 1983

Spur, B., Crea, A., Peters, W., König, W.
Synthesesis and structure determination of 5,6 Epoxy-8,11,14 Z Eicosatrienoic acid and 5-Keto, 8,11,14 Z Eicosatrienoicacid.
Tetrahydron Letters 24:1755-1758, 1983

Spur, B., Crea, A., Peters, W., König, W.
Synthesis and biological activities of 14,15-didehydroleukotrienes and their methylesters.
Archiv Pharmazie 316:968-970, 1983

Brom, J., Raulf, M., Stüning, M., Spur, B., Crea, A., Bremm,K.D., König, W.
Subcellular localization of enzymes involved in leukotriene formation within human polymorphonuclear granulocytes.
Immunology 51:571-583, 1984

Spur, B., Crea, A., Peters, W., König, W.
Synthesis of leukotriene analogs.
Archiv für Pharmazie 317:647-649, 1984

König, W., Bremm, K.D., Theobald, K., Pfeiffer, Ph.,
Szperalski, B., Bohn, A., Borgeat, P., Spur, B., Crea, A.,Falsone, G.
Leukotrienes and lipid factors, mediators and modulators of the inflammatory reactions.
In: "Pathophysiological Mechanisms of Immediate Type Hyper-sensitivity Reactions", Proceedings of the 5th European Immunology Meeting, Istanbul 1982.
In: Recent Advances in Immunology - Plenum Press, 219-224,
1984 (Müftüoglu and Barlas, eds.)

Köller, M., König, W., Spur, B., Crea, A., Peters, W.
Determination of leukotrienes from human plasma by reversed phase HPLC - Characterization of leukotriene metabolizing enzymes.
Biochem. Biophys. Acta 833:128-134, 1985

Köller, M., König, W., Brom, J., Bremm, K.D., Schönfeld, W.Knöller, J.
Functional characteristics of leukotriene C4 and D4 - metabolizing enzymes (y-glutamyltranspeptidase, dipeptidase) within human plasma.
Biochem. Biophys. Acta 836:56-62, 1985

Raulf, M., Stüning, M., König, W.
Metabolism of leukotrienes by L-y-glutamyltranspeptidase and dipeptidase from human polymorphonuclear granulocytes.
Immunology 55:135-147, 1985

Spur, B., Jendralla, H., Crea, A., Peters, W., König, W.
Synthesis of 7Z, 9E, 11Z-leukotrienes, biologically highly active SRS compounds.
Archiv für Pharmazie, 318:567-569, 1985

Köller, M., Brom, J., Raulf, M., König, W.
Cilastatin (MK 0791) is a potent and specific inhibitor of the renal leukotriene D4-dipeptidase.
Biochem. Biophys. Res. Comm. 131:974-979, 1985

Stüning, M., Raulf, M., König, W.
Localization of 5-lipoxygenase within human polymorphonuclear leukocytes.
Biochem. Pharmacol. 34:3943-3950, 1985

Raulf, M., Stüning, M., König, W.
Analysis of leukotriene metabolizing (glutathione-s-transferase, y-glutamyltranspeptidase, dipeptidase) enzymes from human polymorphonuclear granulocytes.
Int. Arch. All. Appl. Immunol. 77:115-117, 1985

Spur, B.,Crea, A., Peters, W., König, W.
Synthesis of leukotriene B3.
Archiv für Pharmazie 318:225-228, 1985

König, W., Knöller, J, Pfeiffer, Ph., Schönfeld, W., Theobald, K., Gross-Weege, W.
Bedeutung der Mastzellen und ihrer Mediatoren für die Auslösung allergischer Erkrankungen.
Teil 1 - Med. Klin. 81:575-580,1986 (Nr. 17); Teil 2 - Med. Klin. 81:612-617,1986 (Nr. 18/19); Teil 3 - Med. Klin. 81:650-655,1986 (Nr. 20)

Raulf, M., Stüning, M., König, W.
Effect of cations on leukotriene release -Requirements for the metabolism of peptido-leukotrienes leukotrienes C4, D4) by human polymorphonuclear granulocytes.
Immunology 58:479-487, 1986

Raulf, M., König, W., Köller, M., Stüning, M.
Release and functional characterization of the leukotriene D4 metabolizing enzyme (dipeptidase) from human polymorphonuclear leukocytes.
Scand. J. Immunol. 25:305-313, 1987

Brom, J., König, W., Stüning, M., Raulf, M., Köller, M.
Characterization of LTB4-omega hydroxylase activity within human polymorphonuclear leukocytes.
Scand. J. Immunol. 25:283-294, 1987

Köller, M., König, W., Knöller, J., Schönfeld, W., Raulf, M., Brom, J.
Die Bedeutung der Leukotriene bei gastrointestinalen Erkrankungen.
Teil I: Die Grundlagen des Leukotrienmetabolismus; Med. Klinik 82:873-876,1987.
Teil II: Die Bedeutung bei gastointestinalen Erkrankungen; Med. Klinik 82:914-918,1987.

Stüning, M., Schultz-Ehrenburg, W., Altmeyer, P., Raulf, M.,König, W.
Metabolism of 14C-Arachidonic acid by polymorphonuclear leukocytes in patients with psoriasis.
Brit. J. Dermatol. 116:153-159, 1987

König, W., Bremm, K.D., Brom J. et al.
The role of leukotriene inducing and metabolizing enzymes in inflammation.
Int. Arch. All. Appl. Immunol. 82:526-531, 1987

König, W., Brom,J., Schönfeld,W., Knöller, J., Stüning, M.
Effect of tenoxicam and indomethacin on the release of histamine, prostaglandin E2 and leukotrienes from various cells.
Arzneimittelforschung, 37(3), 296-299, 1987

Raulf, M., König, W.
Modulation of leukotriene release from human polymorphonuclear leukocytes by phorbol-myristate-acetate and arachidonic acid.
Immunology 64:51-59, 1988

Schlüter, B., Schönfeld, W., König, W.
Generation and metabolism of leukotrienes and release of histamine from human dispersed tonsillar cells.
Scand. J. Immunol. 27:451-459, 1988

Brom, J., Schönfeld, W., König, W.
Metabolism of leukotriene B4 by activated human polymorphonuclear granulocytes.
Immunology 64:509-518, 1988

König, W., Knöller, J., Schönfeld, W.
Mediators and cellular interactions in the lung; In: Local Immunity, Vol. 4 "The Alveolar Macrophage"
Verlag Regensberg & Biermann, ed. C. Sorg, page 119-137, 1988

Schönfeld, W., Schlüter, B., König, W.
Leukotriene generation and metabolism in isolated human lung macrophages.
Immunology 65:529-536, 1988

König, W., Knöller, J., Schönfeld, W.
Mediatoren der Entzündung aus Mastzellen und anderen Zellen des Immunsystems.
Sonderdruck aus Pneumologisches Kolloquium 4
Walter de Gruyter & Co. Berlin - New York, pp.18-34, 1988

Stüning, M., Brom, J., König, W.
Multiple effects of ethylmercurithiosalicylate on the metabolization of arachidonic acid by human neutrophils.
Prostaglandins, Leukotrienes and Essential Fatty Acids 32:1-7, 1988

König, W., Schönfeld, W., Knöller, J., Köller, M.
The role of lipid mediators in asthma (Review).
Allergol. et Immunopathol. 16:289-298, 1988

Brom, J., Knöller, J., Köller, M., König, W.
Tumour necrosis factors modulate the affinity of the leukotriene B4 receptor on human neutrophils.
Immunology 65:647-649, 1988

Köller, M., Brom, Ch., Brom, J., König, W.
Heat shock induces alterations of the lipoxygenase pathway in human polymorphonuclear granulocytes.
Prostaglandins Leukotrienes and Essential Fatty Acids, 38:99-106,1989

Brom C., M. Köller, J. Brom, W. König
Effect of sodium fluoride on the generation of lipoxygenase products from human polymorphonuclear granulocytes, mononuclear cells and platelets - indication for the involvement of G-proteins.
Immunology 68:240-246, 1989

Brom, J., König, W.
Studies on the uptake, binding and metabolites of leukotriene LTB4 by human neutrophils.
Immunology 68:479-485, 1989

König, W., Schönfeld, W.
Derivate des Arachidonsäure-Metabolismus und verwandte Mediatoren.
In: Klinische Immunologie und Allergologie - Teil 1; VEB Gustav Fischer Verlag Jena 1989, pp. 200-219
Herausgegeben von Lothar Jäger unter Mitarbeit von: H. Ambrosius, R. von Baehr, H. Fiebig, P. Frei, E. Fuchs, W. König, G. Pasternak, W. Schneider, W. Schönfeld, N. Sönnichsen und W. Zschiesche.

Schönfeld, W., Saak, A., Steinkamp, G., v.d.Hardt, H.,König, W.
Histamine release from basophils in cystic fibrosis.
Clin. Exp. Immunol.76:434-439, 1989

König, W., Brom, J., Raulf, M., Köller, M.
Induction and Metabolism of Lipid Mediators in Inflammamation.
In: Progress in Allergy and Clinical Immunology
Proceedings of the 13th International Congress of
Allergology and Clinical Immunology -
Hogrefe & Huber Publishers, pp. 47-52,1989.
Toronto - Lewiston, NY - Bern - Göttingen - Stuttgart
W.J. Pichler, B.M. Stadler, C. Dahinden, A.R. Pecoud,
Ph.C. Frei, C. Schneider, A.L. de Weck (eds.)

König, W., Brom, J., Knöller, J., Köller, M., Raulf, M.,Scheffer, J., Schönfeld, W.
The polymorphonuclear granulocyte and leukotrienes -Role in Health and Disease.
In: "Eicosanoids" 3:1-22 - Springer Verlag 1990

Raulf, M., König, W.
Effects of nonsteroidal antiinflammatory compounds (Lonazo-lac Ca, indomethacin, NDGA) on inflammatory mediator generation and release (leukotrienes, PAF, histamine) from various cells.
Immunopharmacology 19:103-111, 1990

König, W., Ulmer, W.T.
Atemwegsobstruktion und Entzündung
In: "Der Internist" - Springer Verlag, Berlin - Heidelberg; 31:262-267, 1990

König, W., Köller, M., Brom, J., Knöller, J., Schönfeld, W.
Parameters of host resistance in acute and chronic infections.
In: "Natural Resistance to Infection", Local Immunity, Vol. 6, page 11-28,1990 - ed. Clemens Sorg; Gustav Fischer Verlag, Stuttgart, New York.

Knöller, J., Brom, J., Schönfeld, W., König, W.
Influence of ciprofloxacin on leukotriene generation from various cells in vitro.
J. Antimicrob. Chemother. 25:605-612, 1990

Knöller, J., Brom, J., Schönfeld, W., König, W.
In-vitro enhancement of leukotriene B4 receptor expression on human neutrophils by cefadroxil.
J. Antimicrob. Chemother. 25:613-620, 1990

Schönfeld, W., Knöller, J., König, W.
The role of leukotrienes in chronic lung diseases.
In: "Late Phase Reactions"
CRC-Press, Boca Raton Ann Arbor, Boston,
ed. Walter Dorsch page 407-437, 1990

Raulf, M., König, W.
Effects of polychlorinated biphenyls on the generation of lipoxygenase products from human polymorphonuclear granulocytes.
Immunology 72:287-291, 1991

Köller, M., König, W.
12-Hydroxyeicosatetraenoic acid (12-HETE) induces heat shock proteins in human leukocytes.
Biochem. Biophys. Res. Comm. 175:804-809, 1991

Raulf, M., König, W.
In vivo effects of polychlorinated biphenyls on human platelets.
Immunology 72:287-291, 1991

Neuber, K., Hilger, R.A., König, W.
Interleukin-3, Interleukin-8, FMLP and C5a enhance the release of leukotrienes from neutrophils of patients with atopic dermatitis.
Immunology 73:197-204, 1991

Brom, C., Brom, J., König, W.
G protein activation and mediator release from human neutrophils and platelets after stimulation with sodium fluoride and receptor mediated stimuli.
Immunology 73:287-292, 1991

Hilger, R., Knöller, J., König, W.
Modulation of leukotriene formation by cellular composition and exogenous leukotriene A4.
Int. Arch. All. Appl. Immunol., 94:254-256, 1991

Brom, J., Brom, C., König, W.
Basic mechanisms of cellular priming and release of inflammatory mediators.
Int. Arch. All. Appl. Immunol. 94:64-67, 1991

Schönfeld, W., Kasimir S., Knöller, J., Jablonski, K.,König, W.
Characterization of the LTB4 metabolism by human monocytes and lung macrophages.
J. Leukocyte Biol. 50:303-312, 1991

Kasimir, S., Schönfeld, W., Hilger, R., König, W.
Analysis of the LTB4 metabolism in human promyelocytic HL-60 cells.
Biochem. J. 279:283-288, 1991

Kasimir, S., Brom, J., König, W.
Effect of Interferon _ on granulocyte functions.
Immunology 74:271-278, 1991

Kasimir, S., Schönfeld, W., Hilger, R., König, W.
Analysis of the LTB4 metabolism in human promyelocytic HL-60 cells.
Biochem. J. 279:283-288, 1991

Schönfeld,W., Kasimir,S., Knöller,J., Jablonski,K., König,W.
Metabolism of leukotriene B4 via reduction into dihydro-leukotriene B4 in human monocytes, alveolar macrophages, and U-937 cells.
J.Leukocyte Biol., 50(3), 303-312, 1991

Hilger, R.A., Neuber, K., König, W.
Conversion of leukotriene A4 by neutrophils and platelets from patients with atopic dermatitis.
Immunology 74:689-695, 1991

Brom, C., Brom, J., König, W.
Neomycin induces stimulatory and inhibitory effects on mediator generation, GTPase activity, and actin polymerization.
Immunology 75:150-156, 1992

Hilger, R.A., Knöller, J., König, W.
Leukotriene A4 mudulates generation of leukotriene B4 and sulphidopeptide leukotrienes by human neutrophils
Immunology, 77:408-415, 1992

Brom, J., König, W.
Signal transduction and priming of human neutrophils.
Int. Arch. All. Appl. Immunol., 99:387-389, 1992

Brom, C., Brom, J., König, W.
GTPases and low molecular weight G-proteins during cell-cell-interaction between neutrophils and platelets.
Int. Arch. All. Appl. Immunol., 99:397-399, 1992

König, W., Köller, M., Brom, J.,
Priming Mechanisms and Induction of Heat Shock Proteins in Human Polymorphonuclear Granulocytes induced by Eicosanoids and Cytokines.
Eicosanoids 5, 539-41, 1992

Brom, J., König, W.
Cytokine-induced (IL-3, IL-6, IL-8 and TNF-ß) activation and deactivation of human neutrophils.
Immunology 75:281-285, 1992

Hilger,R.A., Köller,M., Fränken,J., Rihoux, J.P., König,W.
Interactions of cytokines and lipid mediators in acute and chronic inflammation.
in "Effectors and Pathogenesis of Allergic Diseases"
Int.Arch.All.Appl.Immunol., 107,383-384, 1995

Hilger,R., Köller,M., König,W.
Inhibition of leuktriene formation and IL-8 release by the PAF-receptor antagonist SM-12502
Inflammation 20, 57-70, 1996

Köller, M., Hilger, R.A., König, W.
Effect of the PAF-receptor antagonist SM-12502 on human platelets
Inflammation, 20, 71-85, 1996

Shinoda,I., Takase,M., Fukuwatari,Y.,Shimamura,S., Köller,M., König,W
Effects of Lactoferrin and Lactoferricin? on the release of Interleukin 8 from human polymorphonuclear leukocytes.
Biosci.Biotech.Biochem., 60(3), 521-523, 1996

Köller,M., Hilger,R.A., Rihoux,J.P., König,W.
Cetirizine exerts anti-inflammatory effects on human neutrophils
Int.Arch.All.Appl.Immunol., 110, 52-56, 1996

Köller,M., Hilger,R.A., König,W.
Dual effects of ammonium persulfate on the generation of leukotriene from human neutrophil granulocytes.
Int.Arch.All.Appl.Immunol., 110, 318-324, 1996

Köller,M.,Wachtler,P.,König,W.
Arachidonic acid induces DNA-fragmentation in human polymorphonuclear neutrophilgranulocytes
Inflammation, 21, Nr.5, 463-474, 1997

König, W. and König, B.
The impact of cetirizine on microbial and viral infections
Clinical and Experimental Allergy, 27, Supplement 2, 33-37, 1997

Arnold, R., König, B., König, W.
G-proteins in allergy.
Clin. Exp. Allergy 27, Suppl. 2, S. 1-7, 1997

Kroegel, C., König, W., Jäger, L.
Erweiterte Therapie des Asthma bronchiale: Verwendung von 5-Lipoxygenase-
Inhibitoren und Leukotrien-Rezeptorantagonisten.
Dtsch. Ärztebl., 94, Nr. 26, S. A-1802 - A-1810, 1997

Rihoux, J.P., Masliah.J., Bereziat, G., König, W.
G proteins as biological targets for anti-allergic drugs?
Int Arch Allergy Immunol, 113(1-3), 339-341, 1997

Rihoux, J. P., Michel, L., Arnold, R., König, W.
Hypothetical mechanisms of action of an H1-antihistamine in astma.
Int Arch Allergy Immunol, Feb-Apr; 188 (2-4) 380-3, 1998

Arnold, R., Rihoux, J. P., König, W.
Cetirizine counter-regulates interleukin-8 release from human epithelial cells (A549).
Clinical and Experimental Allergy, Vol. 29, (12) 1681-91, 1999

König, B., Steinbach, F., Janocha, B., Drynda, A., Stumm, M., Philipp, C., Allhoff, E. P. and König, W.
The differential expression of proinflammatory cytokines IL-6, IL-8 and TNF-alpha in renal cell carcinoma.
Anticancer Research, Vol. 19, 1519-1524 special issue, 1999

Ambrosch, A., Borgmann, S., Rihoux, J.-P., König, W.
Effect of the H1-receptor antagonist Cetirizine on the stimulated expression of adhesion molecules and the activation of NFKB in human endothelial cells.
Int. Arch. Allergy Immunol., 124: 362-364, 2001

Borgmann, S., König,W., Kraus, J., Ambrosch, A.
Interferon-gamma balances the proinflammatory pattern in endothelial cells: effect on IL-8 release, adhesion molecule expression and granulocyte adhesion.
Journal of Leukocyte Biology, submitted